Cerebrovascular adverse events (CVAE)

Adverse events reporting

b) Tabular Listing of adverse events

Infections and infestations

In this trial, only serious adverse events and discontinuations due to any adverse events were recorded.

Undesirable effects were usually managed by dose adjustment.

Eye disorders

83 The most common side effects are

The most frequently observed side effects are

Hepato biliary disorders adverse events

The most common side effects are

Few patients experienced serious adverse events

Additional information on individual components in addition to the adverse reactions listed above for the combination product, other adverse reactions previously reported with one of the individual components may be potential adverse reactions with CoAprovel.

Additional information on individual components in addition to the adverse reactions listed above for the combination product, other adverse reactions previously reported with one of the individual components may be potential adverse reactions with Karvezide.

The following adverse events have been reported during post marketing surveillance.

Adverse reactions reported are listed according to the following frequency

31 ) and Grade 4 AEs (34 vs.

(vi) frequency and seriousness of adverse events,

Additional information on individual components in addition to the adverse reactions listed above for the combination product, other adverse events previously reported with one of the individual components may be potential adverse events with Irbesartan Hydrochlorothiazide BMS.

Additional information on individual components in addition to the adverse reactions listed above for the combination product, other adverse events previously reported with one of the individual components may be potential adverse events with Irbesartan Hydrochlorothiazide Winthrop.

Adverse Events of Special Interest (PTs) Serious unexpected reactions (PTs) All events occurring in the following age groups

Cardiac Adverse Event Incidence n, 95 confidence limits

The severity of the adverse events was generally mild to moderate.

The potential risk for humans is unknown.

As the ratio between norethisterone and ethinylestradiol remained similar during interaction with voriconazole, their contraceptive activity would probably not be affected.

Of the 908 participants, 239 thereof experienced adverse events (AEs).

The types and incidences of adverse events reported for patients treated with the combination were similar to the adverse event profile for patients on monotherapy.

The types and incidences of adverse events reported for patients treated with the combination were similar to the adverse event profile for patients on monotherapy.

36 The types and incidences of adverse events reported for patients treated with the combination were similar to the adverse event profile for patients on monotherapy.

49 The types and incidences of adverse events reported for patients treated with the combination were similar to the adverse event profile for patients on monotherapy.

62 The types and incidences of adverse events reported for patients treated with the combination were similar to the adverse event profile for patients on monotherapy.

The events of the past few days clearly demonstrate that we all are deeply committed to the achievement of those objectives.

Adverse reactions to OPTISON are rare and usually of a non serious nature.

The side effects were generally similar to those observed in adults.

The majority of events were mild in severity and resolved with ongoing vildagliptin treatment.

All other common adverse events resolved in the majority of patients.

increased monitoring of adverse events when administered concomitantly with Invirase ritonavir.

increased monitoring of adverse events when administered concomitantly with Invirase ritonavir.

The following adverse reactions have been observed in patients receiving tetracyclines

The following adverse reactions have been reported in post marketing use

For 4S, all the adverse events listed below were recorded.

And so far, there have not been serious adverse events associated with the virus.

The incidence of adverse experiences in EDGE and EDGE II and of adverse experiences considered serious or resulting in discontinuation in the MEDAL study was higher with etoricoxib than diclofenac.

23 of adverse experiences in EDGE and EDGE II and of adverse experiences considered serious or resulting in discontinuation in the MEDAL study was higher with etoricoxib than diclofenac.

Post marketing In addition to the above the following adverse events have been reported during post marketing experience of pravastatin